MTOR and type 2 diabetes mellitus: Fraenkel et al.67observed that mTOR inhibitor rapamycin attenuates adaptation of pancreatic β‐cells to the effect of hyperglycemia and contribute to the exacerbation of metabolic complications in T2D (Figure 5).